Justine R. Stehn is an Oncologist based in Hornsby, NSW. You can find her practice at 502/20 George St, Hornsby, NSW 2077, Australia.
Oncology can sound scary, and it is. In plain terms, Justine looks after people who have cancer, especially when the cancer is complex and needs a careful plan. She also supports families through the hard parts of diagnosis, treatment, and the follow-up that comes after.
Her work includes types of tumours such as Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, and Gliomatosis Cerebri. These conditions are serious, and they can affect the brain and nervous system. In many cases, they’re seen in children, which means the care often needs to be steady, detailed, and centred on what the child (and the whole family) can manage day to day.
Because every case is different, the approach is usually about getting the right information, then making sensible choices about treatment. This can include helping people understand options, setting expectations, and making sure the next steps are clear. At times, treatment plans may change as new results come in, and that’s when having someone who can keep things organised and calm matters a lot.
Oncology appointments can involve a lot of questions. Justine’s focus is on explaining things in a way that helps people feel less lost. Treatments for cancer can bring up side effects and worries, and in many cases it helps to have support for both the physical and emotional side of things.
She works with a team approach too. Cancer care often involves several health professionals working together, so coordination is important. That means talking across the care network, sharing updates, and keeping the plan on track.
Justine’s clinical focus covers the kinds of cancers listed above, along with the broader needs that often come with them, like symptom management and ongoing review. If you’re looking for an oncologist in Hornsby for a complex tumour diagnosis, her practice is located in the heart of the area at George Street.
Details like education history, research focus, and specific clinical trial involvement aren’t listed here, but the main thing that stands out is the clear oncology role and the specific tumour types she looks after.
